1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Unichem Laboratories Limited

Unichem Laboratories Limited

UNICHEMLAB.BO
Unichem Laboratories LimitedIN flagBombay Stock Exchange
372.70
INR
+4.90
- -
26.24BMarket Cap

Total Valuation

Unichem Laboratories Limited carries a market capitalization of 26.24B, placing it among publicly traded companies globally. Its enterprise value stands at 22.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap26.24B
Enterprise Value22.68B

Share Statistics

Unichem Laboratories Limited currently has 70.41M shares outstanding.

Shares Outstanding70.41M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Unichem Laboratories Limited trades at a trailing price-to-earnings ratio of 8.17. The price-to-sales ratio is 0.94, and the price-to-book ratio stands at 146.78.

PE Ratio8.17
PS Ratio0.94
PB Ratio146.78
P/TBV Ratio0.76
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Unichem Laboratories Limited trades at an EV/EBITDA multiple of 40.49 and an EV/FCF ratio of 83.01. The EV/Sales ratio of 1.03 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 40.49 provides insight into valuation relative to core operating earnings.

EV / Sales1.03
EV / EBITDA40.49
EV / EBIT40.49
EV / FCF83.01

Financial Position

Unichem Laboratories Limited maintains a current ratio of 2.48, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 18.41, indicating elevated leverage, while an interest coverage ratio of 1.77 demonstrates limited ability to service its debt obligations.

Current Ratio2.48
Quick Ratio0.34
Debt / Equity18.41
Debt / EBITDA8.93
Interest Coverage1.77

Financial Efficiency

Unichem Laboratories Limited posts a return on equity of 20.35 and a return on invested capital of 1.58.

Return on Equity (ROE)20.35
Return on Assets (ROA)6.92
Return on Invested Capital (ROIC)1.58
Return on Capital Employed (ROCE)16.27
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.04

Taxes

Over the trailing twelve months, Unichem Laboratories Limited has paid 395.40M in income taxes, reflecting an effective tax rate of 13.52.

Income Tax395.40M
Effective Tax Rate13.52

Stock Price Statistics

Unichem Laboratories Limited's stock has declined approximately -38.00216% over the past 52 weeks. The 50-day moving average sits at 347.63, while the 200-day moving average is 417.61.

Beta (5Y)N/A
52-Week Price Change-38.00216%
50-Day Moving Average347.63
200-Day Moving Average417.61
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Unichem Laboratories Limited generated 22.02B in revenue and converted that into 2.53B in net income, yielding earnings per share of 35.92. EBITDA reached 560.10M, while operating income came in at 560.10M.

Revenue22.02B
Gross Profit11.81B
Operating Income560.10M
Pretax Income2.92B
Net Income2.53B
EBITDA560.10M
EBIT560.10M
Earnings Per Share (EPS)35.92

Balance Sheet

Unichem Laboratories Limited holds 2.99B in cash and equivalents against 5.00B in total debt, resulting in a net debt position of 1.79B. Total book value stands at 140.80M, with working capital of 13.11B providing operational flexibility.

Cash & Cash Equivalents2.99B
Total Debt5.00B
Net Debt1.79B
Equity (Book Value)140.80M
Book Value Per Share2.00
Working Capital13.11B

Margins

Unichem Laboratories Limited operates with a gross margin of 53.65, reflecting its pricing power and cost economics. The operating margin of 2.54 and net profit margin of 11.48 provide insight into operational efficiency.

Gross Margin53.65
Operating Margin2.54
Pretax Margin13.28
Profit Margin11.48
EBITDA Margin2.54

Stock Splits

Unichem Laboratories Limited's most recent stock split took place on October 21, 2010 with a 2:5 split ratio.

Last Split Date10/21/2010
Split Ratio2:5

Scores

Unichem Laboratories Limited posts an Altman Z-Score of 2.28, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.28